Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Was the 19/11 last year.

Good day.One of the only BLUE stocks on my monitor.Some good buying at the end and with 3 vs 1 on L2 I would expect to see a quick move up tomorrow.

Another good day. Don;t expect to hold that 10.5p offer for much longer !

I have recently done some legwork and managed to speak at length to the senior management who work for the company on the UVGI division. Here is the latest info I’ve gleaned from ETQ.

Energy Technique already have their new stand alone Nightingale UGVI air conditioning & filtering units in production and available to ship customer orders with delivery in just two weeks.

Most existing air conditioning units in office blocks and public buildings have the air inlet and outlet exhaust grills at ceiling level so do not efficiently exchange the air at floor to desk zone (the lower half of a room). It is at this zone that a very large percentage of the population congregates to work, study, wait or socialise and breath in contagious viruses and germs in the atmosphere. One of the biggest causes of the loss in productivity and profits for industry & commerce is sick leave for the common cold, flu, or other strains of virulent chest infections.

The circle of cross infection with bronchial viruses doesn’t care where it starts but infections most often start with your children who are more prone to respiratory & chest infections and pick them up in the classroom, they take the infection home and give it to their parents who in turn, take it into the office and infect their colleagues who in turn, take it home and infect their children. And so it goes on, ad-infinitum.

ETQ says their Free-Standing Nightingale UGVI Unit, is the ultimate weapon for industry and commerce to significantly reduce the absenteeism in companies’ workforces from these illnesses. The unit has been specifically designed to remove any air that can become contagious with air-born cold & flu viruses from the workplace & frequented public indoor spaces where people congregate. The UGVI units extract air from the floor zone and returns clean decontaminated air to desk & standing height zones where cross infection amongst a workforce would otherwise most likely take place.

With two different sized free-standing “Plug and Play” models now in production and available for delivery, it is now at no better time of the annual season for industry & commerce to buy these units for their workplaces, its late autumn, winter and early spring when they are in most need to prevent cross infection off their staff. National and Local Government Departments and Authorities ought to be the first buyers of the UGVI filtered units for schools, hospitals and other public buildings. ETQ are putting their sales and marketing efforts into winning the orders that eventually will come through as it’s the waiting game for committees and budgets to be approved.

However, ETQ’s Nightingale UVGI division are placing their priorities in their marketing efforts to sell the USP’s of ‘Plug & Play’ UVGI units to Industry and Commerce which they see will have immediate benefits to health & safety in workplaces. In the short term this is the market where they see their first orders will shortly be announced. The units should help UK Industry and Commerce to reduce employee sick leave and save ?Millions p.a. from losses in productivity.

In the medium term, ETQ believe that once the success of the use of the Nightingale UVGI units by Industry and Commerce in the workplace is proven that it significantly reduces the number of productivity hours lost through staff illness and absenteeism from these illnesses then, National & Local Governments would soon follow and buy the units for schools & colleges to protect school children & working families and break the circle of being cross infected.

In the long term, ETQ expect that the UVGI filters will be used in all public bus, coach and rail carriages, passenger ships & aircraft and perhaps eventually could almost eradicate cross infection of air-born viruses and germs. This cross-infection is something that is currently common place in society.

In my view the Nightingale will be a huge sucess for ETQ

http://www.uvgi.co.uk

What a Bullish chart



Good work Leggins.Can you please copy that onto ADVFN ?

Wow!

If that doesnt sound positive I don't know what does.....maybe a little optomistic on the world domination of air filtering..or not? If you don't mind i'll copy and paste it over on ample with credit where it is definately due..well done, thanks, we all knew we were holding on for something and once we see those order announcements then the rise will really start.

GN

See investors are still like Lemmings.Why did the price hold so well today ? A bargain at 11p.

late night Post by Legins on BB of ECK ( in error)


As perhaps you may know, ETQ's management want to get the Nightingale out in the market and being used as quickly as possible. Hence the reason they focused on the two stand-alone portable models first.

The cost of upgrading an existing air conditioning system in large buildings e.g. hospitals etc., would mean an extremely long lead-in time for the budgets for these types of contracts to be approved. This is because it is not just a simple matter of adding the filters to the air conditioning ductwork system but also to lower the position of the air extraction inlet and sanitised air outlet grills from ceilings to extracting air from floor level and deliver sanitised air at desk / standing zone of a room. Therefore, it would be sometime before sales for UVGI filters in existing air-conditioned systems for public, commercial & industrial buildings would show to build-up. New buildings in the future may well be designed to incorporate the Nightingale UVGI filters in new air conditioning systems but this will not happen overnight.

In the mean time, the stand-alone portable Nightingale UVGI filters are an immediately effective air sanitation unit that can work alongside air conditioning systems or on their own. These units give ETQ & UVGI a much faster route into the market and show its products effectiveness. The unit which will be on trial with NHS sometime next month will mean that relative quickly they will not just be accredited by Porton Down 'Dstl' but also by the U.K. public health authorities.

UVGI believe that the first companies to buy & make use of the filters is the Food Processing and Co's in industry, Insurance Co's in commerce & Passenger Cruise Lines Co's in Travel/Leisure industry.

I would have thought that it is near to the time UL labs in USA will have completed tests and accredited with approvals for entering that market. Certainly I think the City has some knowledge and confidence in this coming to fruition and news of this could be any time but are waiting for this to come out before the share price will begin to head north.

OK,

The next thing to find out is

What is the price of their product & what rival products are available or available soon & at what price?

Product Info

http://www.energytechniqueplc.co.uk/admin/upload/files/pdf/brochure3.pdf

ETQ has been mentioned in the Lancet...if it gets into the national press ETQ will fly.

Whats the Lancet?

Lancet is a Top Medical Mag

It is a scientific magazine.

The article recommends that all offices fit UVGI systems to help cut down absenteism due to illness.

apple

You are correct.

Don't get over excited about ETQ.

They have got a good method of killing bugs BUT it looks like they are already on Plan B for making money out of it.

Difficult to get customers to change their existing air conditioning for something new & that is where the big profits are likely to come from.

So quite a good Plan B is to sell a floor standing unit for which there may be a market IF the price is right

& then this will build a reputation for the technology & help them to sell big air conditioning systems with this technology.

What we need to know now is what is the price of the floor standing unit?

BUT this is not really available yet as far as I can tell & is only at the customer evaluation stage NOT in full production.

How far away is full production.

Small company, hardly traded, WIDE SPREAD on share price. How risky is it?

I wondered if Doctors would buy it for their waiting rooms.

Personally, I'm fed up with catching other people's bugs in the waiting room.

So I wondered if the price would be attractive for them to buy it.

1st, it is leased, not sold.
5 Year Lease.

Unfortunately, the Lease is 2000/Year

PLUS

4000/Year Maintainence

Sooooo, I doubt that many of them are going to rush to sign up.

IMHO, this business could build up steadily BUT the SPREAD is rather offputting.

So what do the rest of you think?

Down 2.5%

If it drops a lot more then maybe I might buy.

From todays Independent refering to published report in the Lancet. I think this may be the beginning of the real newsflow that gets the interest back in ETQ

Ultraviolet light in ventilation system cures sick-building syndrome, study claims
By Maxine Frith, Social Affairs Correspondent

28 November 2003

Millions of people who suffer from sick building syndrome could be cured if ultraviolet lights were installed in office ventilation systems, according to a new study.

The lights kill the germs in the environment that cause people to develop ailments at work.

So-called sick building syndrome (SBS) is caused by the increasing use of air conditioning in modern offices. Bacteria can build up in the ventilation systems and leave office workers suffering from a range of problems, such as breathing difficulties, headaches, sore throats, stuffy noses and itchy eyes.

SBS was first recognised in 1982 and is estimated to affect 80 per cent of people who work in air-conditioned offices.

The study into ultraviolet lights was published in the medical journal The Lancet today.

Researchers from the Montreal Chest Institute in Canada tested three offices in the city where people suffered from SBS. They installed UVGI (ultraviolet germicidal irradiation) in the ventilation systems of the buildings and compared reports of illness when the lights were turned on with sickness rates when they were off.

The lights resulted in a 20 per cent reduction in all symptoms. There were 40 per cent fewer complaints about respiratory problems and a 30 per cent reduction in people complaining of stuffy noses. Muscular complaints also halved, according to the study.

Scientists said the UVGI killed the bacteria and molds in ventilation systems. Installing the systems would be relatively cheap and could save companies millions by reducing rates of sickness.

Dick Menzies, the lead researcher, said: "Installation of UVGI in most North American offices could resolve work-related symptoms in about four million employees caused by microbial contamination of heating, ventilation and air-conditioning systems.

"The cost of UVGI installation could, in the long run, prove cost effective compared with the yearly losses from absence because of building related illness." Around 70 per cent of people in the West now work in air-conditioned offices, and SBS is estimated to cost companies millions of pounds a year in reduced productivity and sick days.

Some good posts. Regarding the spread isn't it funny that they will actually pay 10p to buy your shares still !!

Looks like they want some cheap stock !!